Poorer outcomes after non-cardiac surgery in DM

Poorer outcomes after non-cardiac surgery in DM
For patients undergoing non-cardiac surgery, diabetes is associated with adverse perioperative complications and mortality, according to a study published online Aug. 29 in Diabetes Care.

(HealthDay)—For patients undergoing non-cardiac surgery, diabetes is associated with adverse perioperative complications and mortality, according to a study published online Aug. 29 in Diabetes Care.

Chun-Chieh Yeh, M.D., from the China Medical University in Taiwan, and colleagues used reimbursement claims from the Taiwan National Health Insurance system to compare perioperative complications and mortality for patients with and without diabetes undergoing non-cardiac surgery.

The researchers found that the odds of 30-day postoperative mortality were significantly increased for patients with diabetes (odds ratio [OR], 1.84), particularly for those with type 1 or uncontrolled diabetes, as well as for patients with preoperative diabetes-linked comorbidities, including eye involvement, peripheral circulatory disorders, ketoacidosis, renal manifestations, and coma. For patients with diabetes, coexisting medical conditions, including renal dialysis (OR, 5.17), (OR, 3.59), stroke (OR, 2.87), mental disorders (OR, 2.35), ischemic heart disease (OR, 2.08), chronic obstructive pulmonary disease (OR, 1.96), and hyperlipidemia (OR, 1.94), correlated with mortality, compared to controls without diabetes. The risk of postoperative and were significantly increased for patients with diabetes (OR, 3.65 and 2.30, respectively). In addition, there were significant correlations for diabetes with prolonged hospital stay and increased medical expenses (OR, 2.30 and 1.32, respectively).

"Diabetes increases postoperative 30-day mortality, complications, and medical expenditures in patients undergoing in-hospital non-cardiac surgeries," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Risk of comorbidities up with hypoglycemia in T2DM

Apr 08, 2013

(HealthDay)—For patients with type 2 diabetes, hypoglycemia, regardless of its severity, correlates with a significantly increased risk of cardiovascular events, all-cause hospitalization, and mortality, ...

Recommended for you

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

Unexpected turn in diabetes research

Jan 20, 2015

Years of diabetes research carried out on mice whose DNA had been altered with a human growth hormone gene is now ripe for reinterpretation after a new study by researchers at KU Leuven confirms that the gene had an unintended ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.